等待開盤 10-21 09:30:00 美东时间
+0.970
+10.26%
Fortrea has launched a debt tender offer to repurchase up to $75.7 million of its outstanding 7.500% Senior Secured Notes due 2030. The offer, detailed in the Offer to Purchase dated October 20, 2025, aims to comply with indenture provisions requiring the use of net proceeds from divestitures to repurchase a portion of the notes. The tender offer will expire on November 18, 2025, and holders may tender notes through the Depositary Trust Company o...
10-20 11:00
今日重点评级关注:韦德布什:维持Artiva Biotherapeutics"跑赢大市"评级,目标价从18美元升至23美元;巴克莱:维持Cellectis"超配"评级,目标价从4美元升至8美元
10-20 10:03
Mizuho analyst Ann Hynes maintains Fortrea Holdings (NASDAQ:FTRE) with a Neutral and raises the price target from $7 to $9.
10-17 21:18
Providing a diverse range of perspectives from bullish to bearish, 8 analysts h...
10-03 04:01
Fortrea Holdings Inc. ( ($FTRE) ) has shared an update. On September 19, 2025, ...
09-23 04:58
Fortrea announced the appointment of William Sharbaugh to its Board of Directors. With over three decades in the pharmaceutical industry, Sharbaugh brings extensive experience in finance, operations, manufacturing, and quality. Fortrea CEO Anshul Thakral praised Sharbaugh's leadership and ability to deliver high-quality drug development globally. Sharbaugh expressed his enthusiasm to contribute practical insights and collaborate with the Fortrea ...
09-22 20:30
今日重点评级关注:D. Boral Capital:维持Veritone"买入"评级,目标价从6美元升至26美元;Guggenheim:维持Dianthus Therapeutics"买入"评级,目标价从92美元升至100美元
09-10 18:01
Jefferies, in its review of Contract Research Organisations (CRO), has upgraded IQVIA (NYSE:IQV) and Charles River Laboratories (NYSE:CRL) to Buy from Hold while ICON PLC (NASDAQ:ICLR) was cut to Hold...
09-09 22:07
Ratings for Fortrea Holdings (NASDAQ:FTRE) were provided by 6 analysts in the p...
09-03 21:01
Baird analyst Eric Coldwell maintains Fortrea Holdings (NASDAQ:FTRE) with a Outperform and raises the price target from $9 to $14.
09-03 20:06